Why the same mutation in the BRAF gene leads to different therapeutic responses to its inhibitors in melanoma and colorectal cancer
A review article led by researchers from the B·ARGO group at the Germans Trias i Pujol Research…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Subtyping colorectal cancer
Colorectal cancer, or CRC, is the world’s second most lethal cancer based on the number of…
When ovarian cancer alters the abdominal cavity
Ovarian cancer often goes undetected for a long time. In seven out of 10 patients,…
For the first time, a mechanism enabling breast cancer to metastasise to the brain has been deciphered
A large-scale international study, led by researchers from the Gray Faculty of Medical and Health…
Hot flush treatment has anti-breast cancer activity
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen…
Inhalable therapy aims for one-two punch against advanced melanoma
Immune checkpoint molecules play a crucial role in keeping the immune system in balance and…
Researchers discover a mechanism that allows melanoma cancer cells to paralyse immune cells
A new international study led by the Gray Faculty of Medical & Health Sciences at…
Inflammation fuels one of the most aggressive forms of cancer
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer,…
Breast cancer hijacks immune alarm: turning defence into cancer-fuelling inflammation
With a new study in the journal Science Bulletin, researchers at Sun Yat-Sen Memorial Hospital, Sun…
Novel material to enhance cancer immunotherapy
Cancer has long remained a leading cause of death worldwide and in Hong Kong, accounting…